Repligen Corporation Share Price
NASDAQ: RGEN | Micro CapRepligen Corporation Stock Performance
Open $160.23 | Prev. Close $159.44 | Circuit Range N/A |
Day Range $160.23 - $164.81 | Year Range $101.00 - $175.21 | Volume 71,424 |
Average Traded $162.98 |
Repligen Corporation Share Price Today
As of 10 August 2026, Repligen Corporation's share price is $163.85. The stock opened at $160.23, compared to its previous close of $159.44. During today's trading session, Repligen Corporation's share price traded between $160.23 and $164.81, with an average price of $162.52. Over the past 52 weeks, the stock has recorded a high of $175.21 and a low of $101.00. In terms of performance, Repligen Corporation's share price has risen by 27.33% over the last six months and is up 33.97% on a year-on-year basis.
Repligen Corporation Share Price Chart
Repligen Corporation Stock Fundamentals & Key Indicators
Market Cap $9.21M | PE Ratio (TTM) 188.33 | Dividend Yield N/A |
EPS (TTM) $0.87 | Revenue (TTM) -$683.09M | Return On Equity (TTM) 2.32% |
Profit Margin -7.16% | Debt to Equity 0.06 | Quarterly Earnings Growth YoY 2379.97% |
Repligen Corporation Quarterly Profit & Loss
All figures in USD
Repligen Corporation Annual Profit & Loss
All figures in USD
About Repligen Corporation
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Repligen Corporation Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $143.66 | $163.85 | +16.13% |
Jul 2026 | $137.96 | $141.09 | +3.41% |
Jun 2026 | $122.00 | $136.44 | +10.08% |
May 2026 | $117.89 | $123.95 | +4.74% |
Apr 2026 | $118.70 | $118.34 | +0.40% |
Mar 2026 | $126.14 | $117.87 | -8.40% |
Feb 2026 | $150.25 | $128.68 | -13.74% |
Jan 2026 | $163.69 | $149.18 | -8.99% |
Dec 2025 | $169.89 | $163.92 | -4.03% |
Nov 2025 | $148.26 | $170.81 | +14.58% |
Oct 2025 | $139.08 | $149.07 | +11.45% |
Sep 2025 | $120.80 | $133.75 | +9.36% |